Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02839460 · ClinicalTrials.gov registry record
A Prospective Study Of Biomarkers Of Skeletal Muscle Atrophy
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 30
- Enrollment target
NCT02839460 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 30 participants.
The verdict
NCT02839460 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
This is a single center, prospective biomarker study to evaluate serum levels of TWEAK and expression levels of TWEAK and Fn14 in muscle biopsies from patients with sarcopenia as well as healthy, physically active controls.
Interventions
- PROCEDURE Outpatient Muscle Biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2016-11 |
| Est. Completion | 2019-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02839460
The ClinicalTrials.gov registry entry for NCT02839460 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Outpatient Muscle Biopsy is the first listed.
NCT02839460 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02839460 about?
NCT02839460 is a clinical study titled "A Prospective Study Of Biomarkers Of Skeletal Muscle Atrophy". This is a single center, prospective biomarker study to evaluate serum levels of TWEAK and expression levels of TWEAK and Fn14 in muscle biopsies from patients with sarcopenia as well as healthy, physically active controls.
What is the current status of trial NCT02839460?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2016-11. Estimated completion is 2019-03.
What interventions are being tested in trial NCT02839460?
The interventions under investigation include: Outpatient Muscle Biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT02839460?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.